Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7965032 in Geographic Atrophy Secondary to AMD
NCT07851259Phase 2Recruiting
- Sponsor
- Genentech
- Start
- Jan 2027
- Primary completion
- Aug 2030
- Countries
- 1
01
Overview
A Phase 2 trial of RO7965032 in geographic atrophy (GA), sponsored by Genentech. Planned start Jan 2027; status: recruiting.
02
Drugs
RO7965032
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT07851259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07851259.